What Is The Current and Historic Market Size Analysis Of The Catheter-Related Bloodstream Infection Market?
The catheter-related bloodstream infection market has seen considerable growth due to a variety of factors.
• The catheter-related bloodstream infection market has experienced strong growth in recent years. It is expected to increase from $1.53 billion in 2024 to $1.62 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.2%.
The historical growth can be attributed to the rising incidence of chronic diseases, greater awareness and education about infections, the growing elderly population, and improved infection control programs in healthcare facilities.
What Is The Forecast For The Catheter-Related Bloodstream Infection Market Size?
The catheter-related bloodstream infection market is expected to maintain its strong growth trajectory in upcoming years.
• The catheter-related bloodstream infection market is anticipated to reach $2.05 billion by 2029, growing at a CAGR of 6.0%.
This growth is attributed to the rising healthcare-associated infections (HAIs), better awareness and training, improved infection control practices, expanding healthcare infrastructure, and government initiatives. Trends include biomaterial innovations, smart catheter technology, advanced antimicrobial catheter lock solutions, improvements in sterilization processes, and automated flushing systems.
What Are The Essential Drivers Behind The Growth Of The Catheter-Related Bloodstream Infection Market?
The growth of the catheter-related bloodstream infection market is expected to be driven by the rising prevalence of hospital-acquired infections (HAIs). HAIs occur when patients acquire infections during treatment for other conditions, typically manifesting 48 hours or more after admission. Factors such as antimicrobial resistance, insufficient infection control, and patient susceptibility contribute to their increase. Catheter-related bloodstream infections are significant due to their invasive nature and microbial colonization risk. For example, in January 2023, the National Library of Medicine reported a global HAI rate of 0.14%, rising annually by 0.06%. This surge in HAIs will contribute to the market's growth.
How Is The Global Catheter-Related Bloodstream Infection Market Divided Into Key Segments?
The catheter-related bloodstream infection market covered in this report is segmented –
1) By Treatment: Antibiotic Lock Therapy, Anti-Microbial Agents
2) By Source Of Infection Or Causative Agents: Staphylococcus Aureus, Acinetobacter Baumannii, Escherichia Coli (E. Coli), Klebsiella Pneumoniae (K. Pneumonia), Candida Species (Candida Sp.), Pseudomonas Aeruginosa (P. Aeruginosa), Other Source Of Infection Or Causative Agents
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Antibiotic Lock Therapy: Catheter Lock Solutions (Antibiotic-based), Combination Antibiotic Lock Therapy
2) By Anti-Microbial Agents: Antibiotics, Antifungal Agents, Antiseptic Agents
Pre-Book The Catheter-Related Bloodstream Infection Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Catheter-Related Bloodstream Infection Market?
In the catheter-related bloodstream infection market, businesses are developing catheter lock solutions to enhance infection prevention. For example, in November 2023, CorMedix Inc., a US-based biopharmaceutical company, received FDA approval for the DefenCath catheter lock solution, combining antimicrobial properties and anticoagulation to prevent catheter-related infections in patients undergoing chronic hemodialysis.
Who Are the Key Players In The Catheter-Related Bloodstream Infection Market?
Major companies operating in the catheter-related bloodstream infection market are:
• Pfizer Inc.
• Johnson & Johnson Services Inc.
• Novartis AG
• 3M Company
• Eli Lilly and Company
• Fresenius Medical Care AG & Co. KGaA
• Becton Dickinson and Company
• Viatris Inc.
• B. Braun Medical Inc.
• Aurobindo Pharma Limited
• Lupin Ltd.
• Xellia Pharmaceuticals Ltd.
• SteriMax Inc.
• Geistlich Pharma AG
• Bactiguard AB
• Hetero Healthcare Ltd.
• TauroPharm GmbH
• Advacare Pharma
• Citus Pharmaceuticals Inc.
• CorMedix Inc.
• JoinHub Pharma LLP
• IntegraDose Compounding Services LLC
What Are The Regional Insights Into The Catheter-Related Bloodstream Infection Market?
North America was the largest region in the catheter-related bloodstream infection market in 2023. The regions covered in the catheter-related bloodstream infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
